Driven by rising prevalence and awareness of aesthetic appeal and self-image, the Alopecia Areata market is poised for steady growth.
Holly Jenkins, PhD
Advertisement
Holly Jenkins, PhD, is a Consultant at Lifescience Dynamics in London, with a doctorate in neonatology and postdoctoral experience in obstetric medicine. Her consulting experience spans multiple indications, with particular depth in immunology and rheumatology, where she delivers competitive intelligence and actionable insights to clients.
Articles by Holly Jenkins, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
U.S. Supreme Court Unanimously Votes in Favor of Hikma in Case Against Amarin: Report
2
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
3
Alnylam Enters $2 Billion Strategic AI Collaboration with Inceptive
4
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
5